if 3 dedicated US Institutional Holders wanted positions in the company, then at our current Australian prices, they would need to buy virtually every Australian share...
as that won't happen, then the only way 3 Institutional Holders could take up positions is by massively forcing up the SP
-- as there are more than a few US Institutional Holders that pride themselves on being biotech focussed and experts in this field of investment, and where US$100 million is small change for these guys, then don't think they'll sit idle and let their competitors gain the best positions
-- they will fight it out imo, so placing a great deal of pressure on the SP - there is no other way for 3 or more of this big silver backs to get in, than by massively inflating the SP...
or of course, they may just sit the sideline and wait for more results, but that's taking a big risk isn't it?
good luck
PRR Price at posting:
23.3¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)